Preblick Ryan sold INDV
June 8, 2026 · Form 4 insider transaction
Preblick Ryan sold 36,000 shares of Indivior Pharmaceuticals, Inc. at $37.70 per share, a transaction worth $1.36M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
36,000
Price
$37.70
Total value
$1.36M
InsiderPreblick Ryan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 8, 2026
Filing dateJune 10, 2026
Shares owned after284,751
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.